Last 11 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 99.59 | 83.16 | 199.97 | 58.04 | 212.24 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 9.64 | 11.63 | 14.92 | 9.66 | 9.76 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 4.05 | 10.09 | 12.17 | 8.28 | 7.81 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 124.19 | 166.24 | 321.09 | 95.49 | 101.26 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 63.29 | 76.13 | 172.18 | 45.53 | 63.23 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 238.62 | 76.13 | 203.59 | 51.20 | 133.40 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.3% | 70.9% | 70.5% | 73.0% | 71.4% | 69.9% | 65.3% | 64.4% | 57.1% | 52.6% | 51.2% | 50.0% |
| — | +1.3% | +7.9% | +13.3% | +25.2% | +32.9% | +27.4% | +28.9% | — | — | — | — | |
| Operating Margin | 5.3% | 9.0% | 5.0% | 16.5% | 10.8% | 11.5% | -2.4% | -3.9% | -25.9% | -32.9% | -32.0% | -34.2% |
| — | -22.3% | +305.7% | +519.1% | +141.5% | +135.1% | +92.4% | +88.5% | — | — | — | — | |
| Net Margin | 2.4% | 14.1% | 7.4% | 16.6% | 6.2% | 1.8% | -0.4% | -6.8% | -25.5% | -38.8% | -9.2% | -36.0% |
| — | +683.7% | +2091.5% | +345.1% | +124.4% | +104.7% | +96.0% | +81.2% | — | — | — | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.3% | 3.2% | 1.5% | 3.6% | 1.8% | 0.9% | -0.1% | -2.4% | -6.8% | — | — | — |
| — | +265.1% | +1163.5% | +254.1% | +126.5% | — | — | — | — | — | — | — | |
| ROA | 1.6% | 2.3% | 1.1% | 2.7% | 1.2% | 0.5% | -0.1% | -1.3% | -3.8% | — | — | — |
| — | +395.8% | +1530.9% | +307.7% | +132.8% | — | — | — | — | — | — | — | |
| ROIC | 13.5% | 6.0% | 3.4% | 13.0% | 8.3% | 8.0% | -1.4% | -2.0% | -6.9% | — | — | — |
| — | -25.9% | +340.9% | +748.2% | +220.5% | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.23 | 0.25 | 0.27 | 0.29 | 0.23 | 0.60 | 0.63 | 0.63 | 0.65 | — | — | — |
| — | -58.8% | -57.5% | -54.7% | -65.2% | — | — | — | — | — | — | — | |
| Debt / EBITDA | 3.90 | 8.07 | 16.17 | 6.92 | 8.19 | 8.59 | 78.59 | 153.56 | — | — | — | — |
| — | -6.1% | -79.4% | -95.5% | — | — | — | — | — | — | — | — | |
| Current Ratio | 11.69 | 11.25 | 11.69 | 10.92 | 11.69 | 6.17 | 5.92 | 5.92 | 8.03 | — | — | — |
| — | +82.3% | +97.4% | +84.4% | +45.6% | — | — | — | — | — | — | — | |
| Quick Ratio | 11.32 | 10.89 | 11.31 | 10.58 | 11.32 | 5.75 | 5.58 | 5.58 | 7.72 | — | — | — |
| — | +89.5% | +102.8% | +89.7% | +46.7% | — | — | — | — | — | — | — | |
| Interest Coverage | 82.67 | 2899.67 | 940.75 | 1851.90 | 2100.00 | 280.10 | -6.25 | -96.20 | -242.68 | -34.32 | -2.40 | -11.61 |
| — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 11 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BLLN stock.
BillionToOne, Inc.'s current P/E is 99.6x. The average P/E over the last 4 quarters is 138.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
BillionToOne, Inc.'s current operating margin is 5.3%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking BillionToOne, Inc.'s business trajectory between earnings reports.